Brad McConn

Brad McConn serves as the Chief Financial Officer for ImmunoPrecise Antibodies. He is responsible for oversight of the company’s financial reporting, financial planning & analysis, and complex accounting research. Prior to his current role he served as the Director of Financial Planning & Analysis for ImmunoPrecise Antibodies, and previously worked as an analyst in the real estate industry, focusing on a broad range of financial processes and business development. He is a CFA® charterholder, and holds a Bachelor of Arts in Mathematics with Minors in Chemistry and Business.